A validated nomogram integrating hematological indicators to predict response to neoadjuvant therapy in esophageal squamous cell carcinoma patients

BACKGROUND: The prognoses for advanced Esophageal squamous cell cancer (ESCC) was very poor. Neoadjuvant therapy was shown to improve overall survival of ESCC patients. However, there is still no effective indicator to predict the efficacy of neoadjuvant therapy. The present study intended to invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Sichao, Zhou, Zihao, Tian, Dan, Huang, Shujie, Wang, Ce, Gao, Zhen, Ben, Xiaosong, Tang, Jiming, Xie, Liang, Zhou, Haiyu, Zhang, Dongkun, Shi, Ruiqing, Deng, Cheng, Zhuang, Weitao, Ding, Yu, Qiao, Guibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106100/
https://www.ncbi.nlm.nih.gov/pubmed/33987401
http://dx.doi.org/10.21037/atm-21-1628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106100/
https://www.ncbi.nlm.nih.gov/pubmed/33987401
http://dx.doi.org/10.21037/atm-21-1628

Ejemplares similares